Sorafenib plus hepatic arterial infusion chemotherapy versus sorafenib plus transarterial chemoembolization in advanced hepatocellular carcinoma: a phase III trial and biomarker analyses

Journal of the National Cancer Center · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles